Trending Now
Aikido Pharma Inc (NASDAQ:AIKI) Publishes Results Of Its Wake Forest University...
Alkido Pharma Inc (NASDAQ:AIKI) has published a paper titled: “The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein...
Tonix Pharmaceuticals (NASDAQ:TNXP) Enrols First Participant In PRECISION Study Evaluating Immune...
Tonix Pharmaceuticals Holdings Inc. (NASDAQ:TNXP) has enrolled its first participant in the observational PRECISION study, TNX-002. The study examines immune response to coronavirus in...
Amarin (NASDAQ:AMRN)Established That VASCEPA® can Reduce Ischemic Events In Individuals That...
Amarin Corporation Plc. (NASDAQ:AMRN) has announced the presentation of REDUCE-IT® PCI at Transcatheter Cardiovascular Therapeutics Connect during the 32nd Cardiovascular Research Foundation annual scientific...
Popular News
Heat Biologics Inc (NASDAQ: HTBX) Announces Robust T Cell-Mediated Immune Response...
The outbreak of the novel beta-coronavirus from Wuhan, China, has left to over half of the world's population in a status of panic and...
MAKE IT MODERN
LATEST REVIEWS
Axsome Therapeutics Inc. (NASDAQ:AXSM) Announces Development Status For AXS-05 In The...
There are hundreds of people facing unsatisfactory treatments for CNS disorders. Due to the limitation of treatment options, Axsome Therapeutics Inc (NASDAQ:AXSM) has taken...
MAKE IT MODERN
PERFORMANCE TRAINING
Preclinical studies of a COVID-19 vaccine by Altimmune Inc (NASDAQ:ALT) at UAB Shows Potent...
There are hundreds of preclinical studies of a COVID-19 vaccine currently under development. Those in the advanced stages include AdCOVID from Altimmune Inc (NASDAQ:ALT)....
Novus Therapeutics Inc. (NASDAQ:NVUS) Shares Tank After OP0201 Study In Acute Otitis Media Results...
Novus Therapeutics Inc. (NASDAQ:NVUS) shares lost almost 50% of its value after the company delivered disappointing results of its Phase 2a exploratory clinical study...
Altimmune Inc. (NASDAQ:ALT) Commences T-COVID Clinical Trial For Treatment Of Patients With Onset COVID-19...
Altimmune Inc. (NASDAQ:ALT) has announced that the FDA has given the company a go-ahead to proceed with its T-COVID clinical trial. T-COVID is Altimmune’s...
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply Of Baggage Screening...
The commonwealth government of Australia awarded an order worth $5 million to OSI Systems, Inc. (NASDAQ:OSIS). As per the terms of the contract, OSI’s...
Incyte Corporation (NASDAQ:INCY) Reports Positive Overall Response Rates (ORR) From the GEOMETRY mono-1 Study...
Incyte Corporation (NASDAQ:INCY) has exceptional know-how in medicinal chemistry and biology. The global company was founded under a strong motivation, which defined the need...
MAKE IT MODERN
POPULAR
[/tdc_zone]